Wendy Hurlburt, CEO and President of LifeSciencesBC, discusses the reasons behind the booming investment climate for British Columbia life sciences firms and the challenges for start-ups as they build scale. She is in conversation with BIV publisher and editor-in-chief Kirk LaPointe.